Using artificial intelligence to analyze the medical records of more than 120,000 patients with obesity, researchers found that Black people were less likely than non-Black people to undergo metabolic and bariatric surgery (MBS)—even though both groups were equally likely to discuss it with health care providers. In addition, men were both less likely to discuss and receive MBS than women.
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.
"When female patients are struggling with obesity and pregnancy, there is typically a correlation between their weight and infertility."
A team of scientists has shown that intermittent fasting (reducing the number of hours of intake and extending the hours of fasting each day) is an effective method for losing weight and improves cardiovascular health in people with obesity problems.
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.
